News

Agreement reached between the Hebrew University of Jerusalem and the University of Montreal and new collaborations with IRIC

Tel Aviv, May 23, 2017 – As part of his mission to Israel, the Premier of Quebec announced today an agreement between the Hebrew University of Jerusalem and the University of Montreal. It includes the development of new projects in collaboration with the Institute for Research in Immunology and Cancer (IRIC) in the fields of […]

Recipients of the 2017 IRIC Next Generation Awards

21 students will have the chance this summer to conduct a research internship at the Institute, for 12 or 16 weeks and will receive an undergraduate research award, a value of $ 4250 or $ 5670. This opportunity is made possible by the 2017 IRIC Next Generation Awards and the financial contribution from a few […]

Three IRIC students honored at UdeM’s Faculty of Medecine’s Molecular Biology program’s Scientific Day

On May 12th, 50 IRIC students gathered with other students and researchers for the UdeM Faculty of Medecine Molecular Biology Program’s Scientific Day. This event was an opportunity for Master’s and PhD students to present their works with oral and poster presentations. Our students won 3 of the 10 prizes awarded that day for the […]

IRICoR: a unique model

For the annual edition of the Canadian Society for Pharmaceutical Sciences (CSPS) and the Canadian Chapter of the Controlled Release Society (CC-CRS) conferences, Mrs. Nadine Beauger, Chief Executive Officer at the Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR), was invited to present her organization’s model as Université de Montréal’s key […]

The Oncopole announces the appointment of its Executive Director, Ms. Stéphanie Lord-Fontaine

Montréal, May 8, 2017- The Oncopole, a research, development and investment hub designed to accelerate the fight against cancer, announced today the appointment of Ms. Stéphanie Lord-Fontaine as Executive Director of the organization.   Launched in February 2017 through a co-creation partnership of the Fonds de recherche du Québec – Santé (FRQS) and Merck & Co, […]

The Canadian National Proteomics Network honors Dr. Pierre Thibault with the 2017 Tony Pawson Proteomics Award

Dr. Thibault is an internationally renowned leader in mass spectrometry-based proteomics. His research contributions have spanned the elucidation of major environmental toxins, to the deep analysis of the immunopeptidome of cancer cells, to the extensive global characterization of dynamic post-translational modifications. Dr. Thibault served as the Executive Director for Protein Analysis for the biotechnology company […]

The IRIC welcomes two Nobel Laureates

At the invitation of its Chief Executive Officer, Michel Bouvier, the IRIC is proud to welcome two recipients of the Nobel Prize. The Institute received a visit from Brian Kobilka on 26 April and will welcome Robert Lefkowitz on first of June. These visits are in keeping with our efforts to encourage constructive emulation within […]

Identification of a Key Factor Controlling the Production of Blood Cells

The team of Dr. Julie Lessard, principal investigator at the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal and professor at the Department of Pathology and Cell Biology of the Faculty of Medicine, published a study in the prestigious scientific journal Nature Genetics. Conducted in collaboration with Dr. Louis Gaboury and Dr. Guy […]

Claude Perreault Receives the Prestigious Bernhard Cinader Award from the Canadian Society for Immunology (CSI)

It’s in Banff, Alberta, that Dr. Claude Perreault, haematologist and principal investigator at the Institute for Immunology and Cancer (IRIC) at the Université de Montréal, received the Bernhard Cinader Award. He received this award on April 9, as part of the 30th Annual Conference of the Canadian Society for Immunology (CSI) during which he gave […]

ExCellThera, wins the first prize at the HealthKick Challenge, in Toronto

The Institute for Research in Immunology and Cancer — Commercialization of Research (IRICoR) is pleased to announce that its clinical-stage spin-off company, ExCellThera, won the $20,000 first prize in the Pharma & Biotech category at the HealthKick Challenge, which took place in Toronto, Ontario, on April 5th.  ExCellThera, the result of IRICoR’s collaboration with the […]

Next Page »

Follow IRIC

Logo UdeM